{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:11:20Z","timestamp":1777590680625,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.055","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:36:02Z","timestamp":1693294562000},"page":"6083-6092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial"],"prefix":"10.1016","volume":"41","author":[{"given":"Cynthia J.","family":"Snider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalequ","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5932-0821","authenticated-orcid":false,"given":"Amanda L.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Binte Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9878-5920","authenticated-orcid":false,"given":"Mohammad","family":"Yunus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warda","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.V.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-445X","authenticated-orcid":false,"given":"Concepcion F.","family":"Estivariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-5350","authenticated-orcid":false,"given":"Jennifer L.","family":"Konopka-Anstadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-183X","authenticated-orcid":false,"given":"Bernardo A.","family":"Mainou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaymin C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn S.","family":"Lickness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-4818","authenticated-orcid":false,"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.F.","family":"Wassilak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.055_b0005","unstructured":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: conclusions and recommendations. 2022. https:\/\/www.who.int\/publications\/i\/item\/who-wer9724-261-276 (accessed 7 Jul 2022)."},{"issue":"5748","key":"10.1016\/j.vaccine.2023.08.055_b0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.1115547","article-title":"OPV cessation\u2013the final step to a \u201cpolio-free\u201d world","volume":"310","author":"Aylward","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.08.055_b0015","unstructured":"Global Polio Eradication Initiative. Polio Eradication Strategy 2022-2026: Delivering on a Promise. 2021. https:\/\/polioeradication.org\/gpei-strategy-2022-2026\/ (accessed 19 Oct 2022)."},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.055_b0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1473-3099(18)30113-0","article-title":"Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial","volume":"18","author":"Zaman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.055_b0025","unstructured":"Global Polio Eradication Initiative. Standard Operating Procedures: Responding to a poliovirus event or outbreak 2022. https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/07\/Standard-Operating-Procedures-For-Responding-to-a-Poliovirus-Event-Or-Outbreak-20220807-EN-Final.pdf (accessed 26 Apr 2022)."},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.055_b0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication","volume":"33","author":"Caceres","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.055_b0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1473-3099(15)00093-6","article-title":"Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial","volume":"15","author":"Mir","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.055_b0040","doi-asserted-by":"crossref","unstructured":"el-Sayed N, el-Gamal Y, Abbassy AA, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med 2008;359(16):1655-65.","DOI":"10.1056\/NEJMoa0800390"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.055_b0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1473-3099(15)00094-8","article-title":"Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial","volume":"15","author":"Estivariz","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"9753","key":"10.1016\/j.vaccine.2023.08.055_b0050","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.08.055_b0055","unstructured":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2013 - conclusions and recommendations. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23696983 (accessed 22 Sep 2018)."},{"key":"10.1016\/j.vaccine.2023.08.055_b0060","unstructured":"Strategic Advisory Group of Experts on Immunization (SAGE). SAGE October 2022 Meeting Highlights: Strategic Advisory Group of Experts on Immunization (SAGE), 2022. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2022\/october\/highlights_sage_oct_2022.pdf?sfvrsn=69f947c4_5 (accessed 18 Oct 2022)."},{"issue":"6199","key":"10.1016\/j.vaccine.2023.08.055_b0065","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"issue":"9953","key":"10.1016\/j.vaccine.2023.08.055_b0070","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"issue":"8860","key":"10.1016\/j.vaccine.2023.08.055_b0075","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2023.08.055_b0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0264-410X(02)00523-6","article-title":"Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules","volume":"21","author":"Parent du Chatelet","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.055_b0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM200009143431103","article-title":"Trial of a supplemental dose of four poliovirus vaccines","volume":"343","author":"Sutter","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.055_b0090","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.08.055_b0095","article-title":"Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks","author":"Estivariz","year":"2022","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2023.08.055_b0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm6533a5","article-title":"Fractional-dose inactivated poliovirus vaccine immunization campaign - Telangana State, India, June 2016","volume":"65","author":"Bahl","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.055_b0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Estivariz","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"34","key":"10.1016\/j.vaccine.2023.08.055_b0110","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2011.04.133","article-title":"Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials","volume":"29","author":"John","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.055_b0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jir721","article-title":"Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa","volume":"205","author":"Waggie","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.055_b0120","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. https:\/\/www.goodreports.org\/reporting-checklists\/consort\/ (accessed 5 April 2023).","DOI":"10.1016\/j.ijsu.2010.09.006"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.055_b0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2023.08.055_b0130","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium. The REDCap consortium: Building an international community of software partners. J Biomed Inform 2019;95:103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"10.1016\/j.vaccine.2023.08.055_b0135","unstructured":"WHO. WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization, 2006. https:\/\/www.who.int\/tools\/child-growth-standards\/who-multicentre-growth-reference-study (accessed 17 Jul 2018)."},{"key":"10.1016\/j.vaccine.2023.08.055_b0140","unstructured":"WHO. WHO Policy Statement: Multi-dose Vial Policy (MDVP). Handling of multi-dose vaccine vials after opening. 2014. https:\/\/www.who.int\/publications\/i\/item\/WHO-IVB-14.07 (accessed 27 July 2022)."},{"key":"10.1016\/j.vaccine.2023.08.055_b0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.055_b0150","doi-asserted-by":"crossref","first-page":"e0259099","DOI":"10.1371\/journal.pone.0259099","article-title":"Direct detection of polioviruses using a recombinant poliovirus receptor","volume":"16","author":"Gerloff","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.055_b0155","doi-asserted-by":"crossref","first-page":"e0066821","DOI":"10.1128\/Spectrum.00668-21","article-title":"Culture-independent detection of poliovirus in stool samples by direct RNA extraction","volume":"9","author":"Harrington","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2023.08.055_b0160","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/B978-0-323-35761-6.00048-1","article-title":"Poliovirus vaccine\u2013live","author":"Sutter","year":"2018","journal-title":"Plotkin's vaccines: Elsevier"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.055_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41385-021-00428-0","article-title":"Mucosal immunity to poliovirus","volume":"15","author":"Connor","year":"2022","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:10Z","timestamp":1759404730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23010095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23010095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}